Literature DB >> 11909963

Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.

Kevin A Walter1, Mir Ahamed Hossain, Carey Luddy, Nidhi Goel, Thomas E Reznik, John Laterra.   

Abstract

Scatter factor/hepatocyte growth factor (SF/HGF) expression has been linked to malignant progression in glial neoplasms. Using two glioma cell lines, U373MG and SNB-19, we have demonstrated that SF/HGF stimulation allows cells to escape G(1)/G(0) arrest induced by contact inhibition or serum withdrawal. SF/HGF induced effects on two mechanisms of cell cycle regulation: suppression of the cyclin-dependent kinase inhibitor p27 and induction of the transcription factor c-Myc. Regulation of p27 by SF/HGF was posttranslational and is associated with p27 nuclear export. Transient transfections of U373MG and SNB-19 with wild-type p27 and a degradation-resistant p27T187A mutant were insufficient to induce cell cycle arrest, and SF/HGF downregulation of p27 was not necessary for cell cycle reentry. Analysis of Cdk2 kinase activity and p27 binding to cyclin E complexes in the presence of exogenous wild-type p27 or p27T187A demonstrated that Cdk2 activity was not necessary for SF/HGF-mediated G(1)/S transition. Similarly, overexpression of dominant-negative forms of Cdk2 did not block SF/HGF-triggered cell cycle progression. In contrast, SF/HGF transcriptionally upregulated c-Myc, and overexpression of c-Myc was able to prevent G(1)/G(0) arrest in the absence of SF/HGF. Transient overexpression of MadMyc, a dominant-negative chimera for c-Myc, caused G(1)/G(0) arrest in logarithmically growing cells and blocked SF/HGF-mediated G(1)/S transition. c-Myc did not exert its effects through p27 downregulation in these cell lines. SF/HGF induced E2F1-dependent transcription, the inhibition of which did not block SF/HGF-induced cell cycle progression. We conclude that SF/HGF prevents G(1)/G(0) arrest in glioma cell lines by a c-myc-dependent mechanism that is independent of p27, Cdk2, or E2F1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909963      PMCID: PMC133707          DOI: 10.1128/MCB.22.8.2703-2715.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.

Authors:  S G Kim; S N Kim; H S Jong; N K Kim; S H Hong; S J Kim; Y J Bang
Journal:  Oncogene       Date:  2001-03-08       Impact factor: 9.867

3.  A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.

Authors:  W R Sellers; J W Rodgers; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud.

Authors:  F Bladt; D Riethmacher; S Isenmann; A Aguzzi; C Birchmeier
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

5.  Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.

Authors:  R Abounader; S Ranganathan; B Lal; K Fielding; A Book; H Dietz; P Burger; J Laterra
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

6.  Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway.

Authors:  M A Hossain; C M Bouton; J Pevsner; J Laterra
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

7.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Authors:  I Reynisdóttir; K Polyak; A Iavarone; J Massagué
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

8.  Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro.

Authors:  T Moriyama; H Kataoka; H Tsubouchi; M Koono
Journal:  FEBS Lett       Date:  1995-09-18       Impact factor: 4.124

9.  Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.

Authors:  W Arap; R Nishikawa; F B Furnari; W K Cavenee; H J Huang
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

Review 10.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  17 in total

1.  Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.

Authors:  C Rory Goodwin; Bachchu Lal; Xin Zhou; Sandra Ho; Shuli Xia; Alexandra Taeger; Jamie Murray; John Laterra
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

Review 2.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

3.  Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.

Authors:  Zhengtong Pei; Peng Sun; Ping Huang; Bachchu Lal; John Laterra; Paul A Watkins
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 4.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

Review 5.  Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.

Authors:  Roger Abounader; John Laterra
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

6.  Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas.

Authors:  Xian-Zeng Hou; Wei Liu; Hai-Tao Fan; Bin Liu; Bo Pang; Tao Xin; Shang-Chen Xu; Qi Pang
Journal:  Neuro Oncol       Date:  2010-03-03       Impact factor: 12.300

7.  Proliferation and invasion: plasticity in tumor cells.

Authors:  Chong-Feng Gao; Qian Xie; Yan-Li Su; Julie Koeman; Sok Kean Khoo; Margaret Gustafson; Beatrice S Knudsen; Rick Hay; Nariyoshi Shinomiya; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-15       Impact factor: 11.205

8.  Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.

Authors:  Kazuyuki Matsushita; Mai Tamura; Nobuko Tanaka; Takeshi Tomonaga; Hisahiro Matsubara; Hideaki Shimada; David Levens; Liusheng He; Juhong Liu; Minoru Yoshida; Fumio Nomura
Journal:  Mol Cancer Res       Date:  2013-04-17       Impact factor: 5.852

9.  Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

Authors:  Thomas E Reznik; Yingying Sang; Yongxian Ma; Roger Abounader; Eliot M Rosen; Shuli Xia; John Laterra
Journal:  Mol Cancer Res       Date:  2008-01       Impact factor: 5.852

Review 10.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.